首页 › 基金 › Jupiter Topco LLC › BBIO
Jupiter Topco LLC 对 BBIO 的持仓历史
BRIDGEBIO PHARMA INC · 医疗保健
Jupiter Topco LLC 在 Q2 2026 的 13F 申报中披露持有 BBIO(BRIDGEBIO PHARMA INC)14,110,278 股,市值约 US$1.05B,约占其申报组合的 0.44%,在其申报持仓中市值排名第 41 位。 Jupiter Topco LLC 于 Q2 2026 首次申报该持仓。
最后更新: 2026-10-09 · 来源: SEC EDGAR Form 13F-HR
Jupiter Topco LLC 对 BBIO 的持仓演变
Jupiter Topco LLC 于 Q2 2026 首次披露 BBIO 持仓:14,110,278 股(约 US$1.05B)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2026 | 14.11M | $1.05B | 新进 |
关于 BBIO 与 13F 数据
BBIO(BRIDGEBIO PHARMA INC)属于医疗保健行业。我们追踪的基金中还有 47 只申报持有 BBIO,申报仓位最大的包括:骏利亨德森集团 (US$978.6M), 法拉龙资本管理 (US$800.1M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$800.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 BBIO 的基金
- 骏利亨德森集团 13.18M 股 · $978.61M · Q1 2026
- 法拉龙资本管理 10.74M 股 · $800.14M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 10.74M 股 · $800.14M · Q2 2026
- 维京环球投资 9.95M 股 · $741.02M · Q2 2026
- VIKING GLOBAL INVESTORS LP 9.95M 股 · $741.02M · Q2 2026
- Aisling Capital Management LP 4.59M 股 · $341.83M · Q2 2026
- SC US (TTGP), LTD. 1.86M 股 · $138.56M · Q2 2026
- STEELHEAD PARTNERS LLC 70.00M 股 · $124.78M · Q2 2026
- CAPSTONE INVESTMENT ADVISORS, LLC 69.87M 股 · $124.49M · Q2 2026
- Frazier Life Sciences Management, L.P. 1.55M 股 · $115.31M · Q2 2026
- FRONTIER CAPITAL MANAGEMENT CO LLC 1.37M 股 · $102.27M · Q2 2026
- Hood River Capital Management LLC 1.35M 股 · $100.36M · Q2 2026
更多关于 Jupiter Topco LLC
常见问题
How long has Jupiter Topco LLC held BBIO?
Jupiter Topco LLC has disclosed BBIO holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Jupiter Topco LLC's current position in BBIO?
As of Q2 2026, Jupiter Topco LLC holds 14.11M shares of BBIO (BRIDGEBIO PHARMA INC), valued at $1.05B, representing 0.44% of its reported portfolio and ranking #41.
Has Jupiter Topco LLC been buying or selling BBIO?
In the latest 13F filing (Q2 2026), Jupiter Topco LLC newly opened its position in BBIO.
Which other funds hold BBIO?
Other major institutional holders of BBIO include 骏利亨德森集团, 法拉龙资本管理, FARALLON CAPITAL MANAGEMENT, L.L.C., among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.